Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature
Keyword(s):
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
2016 ◽
Vol 40
(6)
◽
pp. 521-528
◽
2020 ◽
Vol 13
(5)
◽
pp. 126-131
2019 ◽
Vol 51
(9)
◽
pp. 2914-2916
◽
2017 ◽
Vol 51
(6)
◽
pp. 476-480
◽
2011 ◽
Vol 27
(7)
◽
pp. 2862-2865
◽
2008 ◽
Vol 39
(3)
◽
pp. 312-319
◽